No takes yet. Share an insight, caveat, or question.
Preclinical study demonstrates that CXCL5 knockdown suppresses tumor growth and invasion in head and neck squamous cell carcinoma, highlighting chemokine signaling as a potential therapeutic target.
Miyazaki et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: